1609264-31-4Relevant academic research and scientific papers
Highly Enantioselective Cross-Electrophile Aryl-Alkenylation of Unactivated Alkenes
Tian, Zhi-Xiong,Qiao, Jin-Bao,Xu, Guang-Li,Pang, Xiaobo,Qi, Liangliang,Ma, Wei-Yuan,Zhao, Zhen-Zhen,Duan, Jicheng,Du, Yun-Fei,Su, Peifeng,Liu, Xue-Yuan,Shu, Xing-Zhong
, (2019/05/16)
Enantioselective cross-electrophile reactions remain a challenging subject in metal catalysis, and with respect to data, studies have mainly focused on stereoconvergent reactions of racemic alkyl electrophiles. Here, we report an enantioselective cross-el
Highly Enantioselective Cross-Electrophile Aryl-Alkenylation of Unactivated Alkenes
Tian, Zhi-Xiong,Qiao, Jin-Bao,Xu, Guang-Li,Pang, Xiaobo,Qi, Liangliang,Ma, Wei-Yuan,Zhao, Zhen-Zhen,Duan, Jicheng,Du, Yun-Fei,Su, Peifeng,Liu, Xue-Yuan,Shu, Xing-Zhong
, p. 7637 - 7643 (2019/05/16)
Enantioselective cross-electrophile reactions remain a challenging subject in metal catalysis, and with respect to data, studies have mainly focused on stereoconvergent reactions of racemic alkyl electrophiles. Here, we report an enantioselective cross-el
INHIBITORS OF CYTOMEGALOVIRUS
-
, (2014/05/24)
Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
